查看購物車
  • Simplified Chinese
  • English
  • Japanese
類器官市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、應用、來源、產品、方法和地理位置
市場調查報告書
商品編碼
1571361

類器官市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、應用、來源、產品、方法和地理位置

Organoids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, Offering, Method, and Geography
出版日期: | 出版商: The Insight Partners | 英文 236 Pages | 訂單完成後即時交付

價格

類器官市場規模預計將從2023年的30.3億美元成長到2031年的150.1億美元；預計 2023 年至 2031 年複合年成長率為 22.3%。類器官市場的成長歸因於對腫瘤建模和生物庫的需求不斷增加，以及個人化藥物的大量採用。然而，缺乏熟練的專業人員和嚴格的安全法規阻礙了市場的成長。公司的關鍵發展可能為市場成長提供機會。

類器官市場已細分為5個主要地區：北美、歐洲、亞太地區、中東和非洲、南美洲和中美洲。北美主導著類器官市場。美國在北美類器官市場佔據主要市場佔有率，其次是加拿大和墨西哥。

根據加拿大健康資訊研究所2023年1月公佈的資料，在加拿大，從2012年到2021年，腎臟替代手術平均每年增加1.4%。 2021年共進行移植2750例，器官捐贈1328例。利用人類誘導的多能幹細胞開發腎臟類器官代表了再生醫學的重要進展。它們預計將用於疾病建模和藥物發現，並可能適用於器官移植。此外，也向研究組織分配了一些資金，以鼓勵類器官的發展。例如，多倫多大學的研究人員在 2019 年至 2021 年期間從 Medicine by Design 獲得了近 2,731 萬美元（2,100 萬加元）的資助。此外，還向 Medicine by Design 提供了 1.483 億美元（1.14 億加元）的贈款，作為加拿大首個卓越研究基金。因此，提供資助是一項策略性舉措，旨在促進再生醫學的變革性發現，並透過工程、醫學和科學的融合加速其產生臨床影響。市場參與者也注重有機成長策略，以鞏固自己的立足點。 2022年4月，BC省兒童醫院基金會在BC省兒童醫院推出了新的幹細胞研究技術。該醫院的目標是在其細胞和再生醫學中心將幹細胞培養的所有方面整合到一台設備中並實現自動化。因此，在預測期內，對類器官開發的不斷成長的投資預計將推動加拿大類器官市場的發展。

依應用分類，類器官市場洞察

根據應用，類器官市場分為發育生物學、傳染病病理學、再生醫學、藥物毒性和功效測試、藥物發現和個人化醫療等。 2023年，發育生物學疾病領域佔最大市場佔有率；預計 2023 年至 2031 年複合年成長率將達到最高。發育生物學是對多細胞生物生長和發育過程的研究；這些過程主要由其基因控制。從培養的幹細胞或組織發育而來的類器官可以轉化為類似完整器官的體內解剖學和生理學的結構。人類類器官培養可用於研究人類發育和疾病模型，其分析深度與非人類模型生物體研究慣用的分析深度相同。隨著技術的進步，3D生物列印已被證明在幫助器官發育方面具有巨大的潛力，因為透過3D列印建立類器官所需的時間比傳統的組織培養方法少得多。源自患者的人類類器官的研究可能會在組織工程和再生醫學等領域帶來新的可能性，為藥物開發研究中的臨床前測試產生知識和工具。

發育生物學應用類器官市場的成長歸因於類器官作為人類發育生物學主要研究工具的接受。此外，從胚胎幹細胞生長的類器官可以提供對胚胎過程發育的完整理解和對幹細胞發育的見解。

在進行類器官市場分析時確定和評估的主要參與者是 STEMCELL Technologies；分子裝置有限責任公司； HUB Organoids BV（Hubrecht Organoid Technology）；定義生成；類器官治療；賽默飛世爾科技公司；康寧公司；默克公司； InSphero； ACRO生物系統公司；和生物技術公司。

2022 年 11 月，ACROBiosystems 開發了一系列高品質的 ActiveMax 細胞因子，以支持類器官細胞培養研究。細胞因子，包括 EGF、Noggin、R-Spondin 1、FGF10、FGF2 和 Activin A，可作為類器官培養的生長因子，並已被證實可促進類器官生長。

2023 年 7 月，Molecular Devices, LLC 利用專有的生物反應器和生物製程技術，擴大了標準化、可用於分析的類器官的生產，擴大了其類器官產品線服務，以支持下一代藥物發現。

2023 年 2 月，Thermo Fisher Scientific 和 Celltrio 合作為生物治療客戶帶來全自動細胞培養系統。此次合作將 Thermo Scientific Momentum 工作流程調度軟體與 Celltrio RoboCell細胞株自動化平台相整合，以滿足高通量自動化細胞株培養和維護方面未滿足的市場需求

投資者介紹、世界衛生組織、美國國立衛生研究院、美國食品藥物管理局 (FDA) 藥物評估與研究中心 (CDER)、美國勞工統計局是在準備報告時參考的一些主要二手來源。器官市場的報告。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：
  • PEST分析

第 4 章：類器官市場 - 主要市場動態

  • 類器官市場 - 主要市場動態
  • 市場促進因素
    • 對腫瘤建模和生物樣本庫的需求不斷增加
    • 個人化藥物的採用激增
  • 市場限制
    • 缺乏熟練的專業人員
  • 市場機會
    • 專注於藥物發現活動
  • 未來趨勢
    • 類器官和器官晶片的組合
  • 促進因素和限制的影響：

第 5 章：類器官市場 - 全球市場分析

  • 類器官市場收入，2021-2031
  • 類器官市場預測分析

第 6 章：類器官市場分析 - 按類型

  • 腸
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 腦
  • 腎
  • 其他

第 7 章：類器官市場分析 - 按應用

  • 發育生物學疾病
  • 傳染病病理學
  • 再生醫學
  • 藥物毒性和藥效測試
  • 藥物發現與個人化醫療
  • 其他

第 8 章：類器官市場分析 - 按來源

  • 多能幹細胞
  • 器官特異性成體幹細胞

第 9 章：類器官市場分析 - 按產品

  • 儀器儀表
  • 耗材
  • 服務

第 10 章：類器官市場分析 - 按方法

  • 微圖案板
  • 超低連接板
  • 懸滴
  • 微滴/乳液
  • 其他

第 11 章：類器官市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：產業格局

  • 概述
  • 類器官市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • STEMCELL Technologies Inc
  • Molecular Devices, LLC.
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero
  • ACRO Biosystems.
  • Bio-Techne Corp
  • SUN bioscience SA
  • ORGANOID SCIENCES Co., Ltd.
  • Crown Bioscience Inc
  • Sartorius AG
  • 3D Biotek LLC
  • Prellis Biologics Inc.
  • 3Dnamics Inc.
  • Cellesce Ltd

第 14 章：附錄

Product Code: TIPRE00017616

The organoids market size is expected to grow from US$ 3.03 billion in 2023 to US$ 15.01 billion by 2031; it is projected to register a CAGR of 22.3% during 2023-2031. The organoids market growth is attributed to the increasing demand for tumor modeling & biobanking, and a surging adoption of personalized drugs. However, the dearth of skilled professionals and stringent safety regulations hinder the growth of the market. Key developments by companies are likely to offer opportunities for market growth.

The organoids market has been segmented into the 5 major regions: North America, Europe, Asia Pacific, Middle East and Africa, South and Central America. North America dominates the organoids market. US held the major market share in the North America organoids market followed by Canada and Mexico.

In Canada, renal replacement procedures increased with an average rate of 1.4% per year from 2012 to 2021, as per the data published by the Canadian Institute for Health Information in January 2023. In the same period, organ donation and transplantation increased by 23%. A total of 2,750 transplantations occurred in 2021, while the count of organ donations was 1,328. The development of kidney organoids from human-induced pluripotent stem cells represents an essential advancement in regenerative medicine. They are expected to be used for disease modeling and drug discovery and might be applicable for organ transplantation. Moreover, several funds are allocated to research organizations to encourage the development of organoids. For instance, researchers at the University of Toronto received nearly US$ 27.31 million (CA$ 21 million) in funding from Medicine by Design during 2019-2021. Also, a US$ 148.3 million (CA$ 114 million) grant was provided to Medicine by Design as the Canada First Research Excellence Fund. Therefore, offering grants is a strategic initiative to catalyze transformative findings in regenerative medicine and accelerate them toward clinical impact through the convergence of engineering, medicine, and science. Market players are also focusing on organic growth strategies to strengthen their foothold. In April 2022, BC Children's Hospital Foundation launched new stem cell research technology at BC Children's Hospital. The hospital aims to combine and automate all aspects of stem cell culturing into a single piece of equipment at its Cellular and Regenerative Medicine Centre. Thus, the growing investment in the development of organoids is expected to fuel the organoids market in Canada over the forecast period.

By Application, Organoids Market-Based Insights

Based on application, the organoids market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023-2031. Developmental biology is the study of processes involved in the growth and development of multicellular organisms; these processes are predominantly controlled by their genes. Organoids developed from stem cells or tissues in culture can be transformed into structures that resemble the in-vivo anatomy and physiology of intact organs. Human organoid cultures can be used to study human development and model diseases with the same depth of analysis that is customary for research with nonhuman model organisms. With technological advancements, 3D bioprinting have been shown to possess massive potential to aid in organ development, as the time required for building organoids through 3D printing is much less than traditional tissue culture methods. Studies enabled by patient-derived human organoids may lead to new possibilities in the fields such as tissue engineering and regenerative medicine, generating knowledge and tools for preclinical testing in drug development studies.

The growth of the organoids market for developmental biology applications is attributed to the acceptance of organoids as the primary investigative research tool in human developmental biology. Moreover, organoids grown from embryonic stem cells offer a complete understanding of embryonic process development and insights into stem cell development.

Key players identified and evaluated while performing organoids market analysis are STEMCELL Technologies; Molecular Devices, LLC.; HUB Organoids B.V. (Hubrecht Organoid Technology); DefiniGEN; Organoid Therapeutics; Thermo Fisher Scientific Inc.; Corning Inc.; Merck KGaA; InSphero; ACRO Biosystems; and Bio-Techne Corporation.

In Nov-2022, ACROBiosystems developed a series of high-quality ActiveMax cytokines to support research on organoid cell culturing. The cytokines, including EGF, Noggin, R-Spondin 1, FGF10, FGF2, and Activin A, serve as growth factors for organoid culture and have been verified to promote organoid growth.

In Jul-2023, Molecular Devices, LLC expanded its organoid line services to support next-generation drug discovery by scaling up the production of standardized, assay-ready organoids, leveraging proprietary bioreactor and bioprocess technology.

In Feb-2023, Thermo Fisher Scientific and Celltrio collaborated to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum workflow scheduling software with the Celltrio RoboCell cell line automation platform to address the unmet market need for high-throughput automated cell line culturing and maintenance

Investor Presentation, World Health Organization, National Institutes of Health, Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA), US Bureau of Labor Statistics, are a few of the major secondary sources referred to while preparing the report on the organoids market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 PEST Analysis

4. Organoids Market - Key Market Dynamics

  • 4.1 Organoids Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Tumor Modeling and Biobanking
    • 4.2.2 Surging Adoption of Personalized Drugs
  • 4.3 Market Restraints
    • 4.3.1 Dearth of Skilled Professionals
  • 4.4 Market Opportunities
    • 4.4.1 Focus on Drug Discovery Activities
  • 4.5 Future Trends
    • 4.5.1 Combination of Organoids and Organ-on-a-Chip
  • 4.6 Impact of Drivers and Restraints:

5. Organoids Market - Global Market Analysis

  • 5.1 Organoids Market Revenue (US$ Million), 2021-2031
  • 5.2 Organoids Market Forecast Analysis

6. Organoids Market Analysis - by Type

  • 6.1 Intestine
    • 6.1.1 Overview
    • 6.1.2 Intestine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Liver
    • 6.2.1 Overview
    • 6.2.2 Liver: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Stomach
    • 6.3.1 Overview
    • 6.3.2 Stomach: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.4 Pancreas
    • 6.4.1 Overview
    • 6.4.2 Pancreas: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.5 Lung
    • 6.5.1 Overview
    • 6.5.2 Lung: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.6 Brain
    • 6.6.1 Overview
    • 6.6.2 Brain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.7 Kidney
    • 6.7.1 Overview
    • 6.7.2 Kidney: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

7. Organoids Market Analysis - by Application

  • 7.1 Developmental Biology Disease
    • 7.1.1 Overview
    • 7.1.2 Developmental Biology Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Pathology of Infectious Disease
    • 7.2.1 Overview
    • 7.2.2 Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Regenerative Medicine
    • 7.3.1 Overview
    • 7.3.2 Regenerative Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Drug Toxicity and Efficacy Testing
    • 7.4.1 Overview
    • 7.4.2 Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Drug Discovery and Personalized Medicine
    • 7.5.1 Overview
    • 7.5.2 Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

8. Organoids Market Analysis - by Source

  • 8.1 Pluripotent Stem Cells
    • 8.1.1 Overview
    • 8.1.2 Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Organ Specific Adult Stem Cell
    • 8.2.1 Overview
    • 8.2.2 Organ Specific Adult Stem Cell: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

9. Organoids Market Analysis - by Offerings

  • 9.1 Instruments
    • 9.1.1 Overview
    • 9.1.2 Instruments: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Consumables
    • 9.2.1 Overview
    • 9.2.2 Consumables: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Services
    • 9.3.1 Overview
    • 9.3.2 Services: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

10. Organoids Market Analysis - by Method

  • 10.1 Micropatterned Plates
    • 10.1.1 Overview
    • 10.1.2 Micropatterned Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Ultralow Attachment Plates
    • 10.2.1 Overview
    • 10.2.2 Ultralow Attachment Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Hanging Drop
    • 10.3.1 Overview
    • 10.3.2 Hanging Drop: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Microdroplet/Emulsion
    • 10.4.1 Overview
    • 10.4.2 Microdroplet/Emulsion: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

11. Organoids Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Organoids Market Overview
    • 11.2.2 North America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.2.3 North America: Organoids Market Breakdown, by Type
      • 11.2.3.1 North America: Organoids Market - Revenue and Forecast Analysis - by Type
    • 11.2.4 North America: Organoids Market Breakdown, by Application
      • 11.2.4.1 North America: Organoids Market - Revenue and Forecast Analysis - by Application
    • 11.2.5 North America: Organoids Market Breakdown, by Source
      • 11.2.5.1 North America: Organoids Market - Revenue and Forecast Analysis - by Source
    • 11.2.6 North America: Organoids Market Breakdown, by Offerings
      • 11.2.6.1 North America: Organoids Market - Revenue and Forecast Analysis - by Offerings
    • 11.2.7 North America: Organoids Market Breakdown, by Method
      • 11.2.7.1 North America: Organoids Market - Revenue and Forecast Analysis - by Method
    • 11.2.8 North America: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.2.8.1 North America: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.2.8.2 United States: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.8.2.1 United States: Organoids Market Breakdown, by Type
        • 11.2.8.2.2 United States: Organoids Market Breakdown, by Application
        • 11.2.8.2.3 United States: Organoids Market Breakdown, by Source
        • 11.2.8.2.4 United States: Organoids Market Breakdown, by Offerings
        • 11.2.8.2.5 United States: Organoids Market Breakdown, by Method
      • 11.2.8.3 Canada: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.8.3.1 Canada: Organoids Market Breakdown, by Type
        • 11.2.8.3.2 Canada: Organoids Market Breakdown, by Application
        • 11.2.8.3.3 Canada: Organoids Market Breakdown, by Source
        • 11.2.8.3.4 Canada: Organoids Market Breakdown, by Offerings
        • 11.2.8.3.5 Canada: Organoids Market Breakdown, by Method
      • 11.2.8.4 Mexico: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.8.4.1 Mexico: Organoids Market Breakdown, by Type
        • 11.2.8.4.2 Mexico: Organoids Market Breakdown, by Application
        • 11.2.8.4.3 Mexico: Organoids Market Breakdown, by Source
        • 11.2.8.4.4 Mexico: Organoids Market Breakdown, by Offerings
        • 11.2.8.4.5 Mexico: Organoids Market Breakdown, by Method
  • 11.3 Europe
    • 11.3.1 Europe Organoids Market Overview
    • 11.3.2 Europe: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.3.3 Europe: Organoids Market Breakdown, by Type
      • 11.3.3.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Type
    • 11.3.4 Europe: Organoids Market Breakdown, by Application
      • 11.3.4.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Application
    • 11.3.5 Europe: Organoids Market Breakdown, by Source
      • 11.3.5.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Source
    • 11.3.6 Europe: Organoids Market Breakdown, by Offerings
      • 11.3.6.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Offerings
    • 11.3.7 Europe: Organoids Market Breakdown, by Method
      • 11.3.7.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Method
    • 11.3.8 Europe: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.3.8.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.3.8.2 Germany: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.2.1 Germany: Organoids Market Breakdown, by Type
        • 11.3.8.2.2 Germany: Organoids Market Breakdown, by Application
        • 11.3.8.2.3 Germany: Organoids Market Breakdown, by Source
        • 11.3.8.2.4 Germany: Organoids Market Breakdown, by Offerings
        • 11.3.8.2.5 Germany: Organoids Market Breakdown, by Method
      • 11.3.8.3 France: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.3.1 France: Organoids Market Breakdown, by Type
        • 11.3.8.3.2 France: Organoids Market Breakdown, by Application
        • 11.3.8.3.3 France: Organoids Market Breakdown, by Source
        • 11.3.8.3.4 France: Organoids Market Breakdown, by Offerings
        • 11.3.8.3.5 France: Organoids Market Breakdown, by Method
      • 11.3.8.4 United Kingdom: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.4.1 United Kingdom: Organoids Market Breakdown, by Type
        • 11.3.8.4.2 United Kingdom: Organoids Market Breakdown, by Application
        • 11.3.8.4.3 United Kingdom: Organoids Market Breakdown, by Source
        • 11.3.8.4.4 United Kingdom: Organoids Market Breakdown, by Offerings
        • 11.3.8.4.5 United Kingdom: Organoids Market Breakdown, by Method
      • 11.3.8.5 Italy: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.5.1 Italy: Organoids Market Breakdown, by Type
        • 11.3.8.5.2 Italy: Organoids Market Breakdown, by Application
        • 11.3.8.5.3 Italy: Organoids Market Breakdown, by Source
        • 11.3.8.5.4 Italy: Organoids Market Breakdown, by Offerings
        • 11.3.8.5.5 Italy: Organoids Market Breakdown, by Method
      • 11.3.8.6 Spain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.6.1 Spain: Organoids Market Breakdown, by Type
        • 11.3.8.6.2 Spain: Organoids Market Breakdown, by Application
        • 11.3.8.6.3 Spain: Organoids Market Breakdown, by Source
        • 11.3.8.6.4 Spain: Organoids Market Breakdown, by Offerings
        • 11.3.8.6.5 Spain: Organoids Market Breakdown, by Method
      • 11.3.8.7 Rest of Europe: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.7.1 Rest of Europe: Organoids Market Breakdown, by Type
        • 11.3.8.7.2 Rest of Europe: Organoids Market Breakdown, by Application
        • 11.3.8.7.3 Rest of Europe: Organoids Market Breakdown, by Source
        • 11.3.8.7.4 Rest of Europe: Organoids Market Breakdown, by Offerings
        • 11.3.8.7.5 Rest of Europe: Organoids Market Breakdown, by Method
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Organoids Market Overview
    • 11.4.2 Asia Pacific: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.4.3 Asia Pacific: Organoids Market Breakdown, by Type
      • 11.4.3.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Type
    • 11.4.4 Asia Pacific: Organoids Market Breakdown, by Application
      • 11.4.4.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Application
    • 11.4.5 Asia Pacific: Organoids Market Breakdown, by Source
      • 11.4.5.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Source
    • 11.4.6 Asia Pacific: Organoids Market Breakdown, by Offerings
      • 11.4.6.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Offerings
    • 11.4.7 Asia Pacific: Organoids Market Breakdown, by Method
      • 11.4.7.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Method
    • 11.4.8 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.4.8.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.4.8.2 Japan: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.2.1 Japan: Organoids Market Breakdown, by Type
        • 11.4.8.2.2 Japan: Organoids Market Breakdown, by Application
        • 11.4.8.2.3 Japan: Organoids Market Breakdown, by Source
        • 11.4.8.2.4 Japan: Organoids Market Breakdown, by Offerings
        • 11.4.8.2.5 Japan: Organoids Market Breakdown, by Method
      • 11.4.8.3 China: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.3.1 China: Organoids Market Breakdown, by Type
        • 11.4.8.3.2 China: Organoids Market Breakdown, by Application
        • 11.4.8.3.3 China: Organoids Market Breakdown, by Source
        • 11.4.8.3.4 China: Organoids Market Breakdown, by Offerings
        • 11.4.8.3.5 China: Organoids Market Breakdown, by Method
      • 11.4.8.4 India: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.4.1 India: Organoids Market Breakdown, by Type
        • 11.4.8.4.2 India: Organoids Market Breakdown, by Application
        • 11.4.8.4.3 India: Organoids Market Breakdown, by Source
        • 11.4.8.4.4 India: Organoids Market Breakdown, by Offerings
        • 11.4.8.4.5 India: Organoids Market Breakdown, by Method
      • 11.4.8.5 South Korea: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.5.1 South Korea: Organoids Market Breakdown, by Type
        • 11.4.8.5.2 South Korea: Organoids Market Breakdown, by Application
        • 11.4.8.5.3 South Korea: Organoids Market Breakdown, by Source
        • 11.4.8.5.4 South Korea: Organoids Market Breakdown, by Offerings
        • 11.4.8.5.5 South Korea: Organoids Market Breakdown, by Method
      • 11.4.8.6 Australia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.6.1 Australia: Organoids Market Breakdown, by Type
        • 11.4.8.6.2 Australia: Organoids Market Breakdown, by Application
        • 11.4.8.6.3 Australia: Organoids Market Breakdown, by Source
        • 11.4.8.6.4 Australia: Organoids Market Breakdown, by Offerings
        • 11.4.8.6.5 Australia: Organoids Market Breakdown, by Method
      • 11.4.8.7 Rest of APAC: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.7.1 Rest of APAC: Organoids Market Breakdown, by Type
        • 11.4.8.7.2 Rest of APAC: Organoids Market Breakdown, by Application
        • 11.4.8.7.3 Rest of APAC: Organoids Market Breakdown, by Source
        • 11.4.8.7.4 Rest of APAC: Organoids Market Breakdown, by Offerings
        • 11.4.8.7.5 Rest of APAC: Organoids Market Breakdown, by Method
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Organoids Market Overview
    • 11.5.2 Middle East and Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.5.3 Middle East and Africa: Organoids Market Breakdown, by Type
      • 11.5.3.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Type
    • 11.5.4 Middle East and Africa: Organoids Market Breakdown, by Application
      • 11.5.4.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Application
    • 11.5.5 Middle East and Africa: Organoids Market Breakdown, by Source
      • 11.5.5.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Source
    • 11.5.6 Middle East and Africa: Organoids Market Breakdown, by Offerings
      • 11.5.6.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Offerings
    • 11.5.7 Middle East and Africa: Organoids Market Breakdown, by Method
      • 11.5.7.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Method
    • 11.5.8 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.5.8.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.5.8.2 Saudi Arabia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.8.2.1 Saudi Arabia: Organoids Market Breakdown, by Type
        • 11.5.8.2.2 Saudi Arabia: Organoids Market Breakdown, by Application
        • 11.5.8.2.3 Saudi Arabia: Organoids Market Breakdown, by Source
        • 11.5.8.2.4 Saudi Arabia: Organoids Market Breakdown, by Offerings
        • 11.5.8.2.5 Saudi Arabia: Organoids Market Breakdown, by Method
      • 11.5.8.3 South Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.8.3.1 South Africa: Organoids Market Breakdown, by Type
        • 11.5.8.3.2 South Africa: Organoids Market Breakdown, by Application
        • 11.5.8.3.3 South Africa: Organoids Market Breakdown, by Source
        • 11.5.8.3.4 South Africa: Organoids Market Breakdown, by Offerings
        • 11.5.8.3.5 South Africa: Organoids Market Breakdown, by Method
      • 11.5.8.4 United Arab Emirates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.8.4.1 United Arab Emirates: Organoids Market Breakdown, by Type
        • 11.5.8.4.2 United Arab Emirates: Organoids Market Breakdown, by Application
        • 11.5.8.4.3 United Arab Emirates: Organoids Market Breakdown, by Source
        • 11.5.8.4.4 United Arab Emirates: Organoids Market Breakdown, by Offerings
        • 11.5.8.4.5 United Arab Emirates: Organoids Market Breakdown, by Method
      • 11.5.8.5 Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.8.5.1 Rest of Middle East and Africa: Organoids Market Breakdown, by Type
        • 11.5.8.5.2 Rest of Middle East and Africa: Organoids Market Breakdown, by Application
        • 11.5.8.5.3 Rest of Middle East and Africa: Organoids Market Breakdown, by Source
        • 11.5.8.5.4 Rest of Middle East and Africa: Organoids Market Breakdown, by Offerings
        • 11.5.8.5.5 Rest of Middle East and Africa: Organoids Market Breakdown, by Method
  • 11.6 South and Central America
    • 11.6.1 South and Central America Organoids Market Overview
    • 11.6.2 South and Central America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.6.3 South and Central America: Organoids Market Breakdown, by Type
      • 11.6.3.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Type
    • 11.6.4 South and Central America: Organoids Market Breakdown, by Application
      • 11.6.4.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Application
    • 11.6.5 South and Central America: Organoids Market Breakdown, by Source
      • 11.6.5.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Source
    • 11.6.6 South and Central America: Organoids Market Breakdown, by Offerings
      • 11.6.6.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Offerings
    • 11.6.7 South and Central America: Organoids Market Breakdown, by Method
      • 11.6.7.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Method
    • 11.6.8 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.6.8.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.6.8.2 Brazil: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.6.8.2.1 Brazil: Organoids Market Breakdown, by Type
        • 11.6.8.2.2 Brazil: Organoids Market Breakdown, by Application
        • 11.6.8.2.3 Brazil: Organoids Market Breakdown, by Source
        • 11.6.8.2.4 Brazil: Organoids Market Breakdown, by Offerings
        • 11.6.8.2.5 Brazil: Organoids Market Breakdown, by Method
      • 11.6.8.3 Argentina: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.6.8.3.1 Argentina: Organoids Market Breakdown, by Type
        • 11.6.8.3.2 Argentina: Organoids Market Breakdown, by Application
        • 11.6.8.3.3 Argentina: Organoids Market Breakdown, by Source
        • 11.6.8.3.4 Argentina: Organoids Market Breakdown, by Offerings
        • 11.6.8.3.5 Argentina: Organoids Market Breakdown, by Method
      • 11.6.8.4 Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.6.8.4.1 Rest of South and Central America: Organoids Market Breakdown, by Type
        • 11.6.8.4.2 Rest of South and Central America: Organoids Market Breakdown, by Application
        • 11.6.8.4.3 Rest of South and Central America: Organoids Market Breakdown, by Source
        • 11.6.8.4.4 Rest of South and Central America: Organoids Market Breakdown, by Offerings
        • 11.6.8.4.5 Rest of South and Central America: Organoids Market Breakdown, by Method

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Organoids Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 STEMCELL Technologies Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Molecular Devices, LLC.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Hubrecht Organoid Technology
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Definigen
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Organoid Therapeutics
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Thermo Fisher Scientific Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Merck KGaA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 InSphero
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ACRO Biosystems.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Techne Corp
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 SUN bioscience SA
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 ORGANOID SCIENCES Co., Ltd.
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Crown Bioscience Inc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Sartorius AG
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 3D Biotek LLC
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Prellis Biologics Inc.
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 3Dnamics Inc.
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments
  • 13.19 Cellesce Ltd
    • 13.19.1 Key Facts
    • 13.19.2 Business Description
    • 13.19.3 Products and Services
    • 13.19.4 Financial Overview
    • 13.19.5 SWOT Analysis
    • 13.19.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners

List Of Tables

  • Table 1. Organoids Market Segmentation
  • Table 2. Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Source
  • Table 6. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Offerings
  • Table 7. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Method
  • Table 8. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 9. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 11. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 12. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 13. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 14. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 15. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 16. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 17. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 18. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 19. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 20. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 21. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 22. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 23. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 24. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 25. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 26. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 27. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 28. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 29. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 30. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 31. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 32. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 33. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 34. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 35. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 36. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 37. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 38. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 39. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 40. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 41. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 42. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 43. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 44. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 45. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 46. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 47. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 48. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 49. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 50. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 51. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 52. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 53. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 54. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 55. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 56. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 57. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 58. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 59. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 60. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 61. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 62. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 63. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 64. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 65. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 66. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 67. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 68. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 69. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 70. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 71. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 72. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 73. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 74. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 75. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 76. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 77. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 78. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 79. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 80. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 81. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 82. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 83. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 84. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 85. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 86. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 87. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 88. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 89. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 90. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 91. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 92. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 93. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 94. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 95. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 96. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 97. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 98. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 99. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 100. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 101. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 102. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 103. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 104. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 105. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 106. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 107. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 108. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 109. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 110. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 111. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 112. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 113. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 114. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 115. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 116. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 117. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 118. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 119. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 120. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 121. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 122. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 123. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 124. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 125. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 126. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 127. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 128. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 129. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 130. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 131. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 132. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 133. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 134. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 135. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 136. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 137. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 138. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 139. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 140. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 141. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 142. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 143. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 144. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 145. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 146. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 147. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 148. Recent Organic Growth Strategies in Organoids Market
  • Table 149. Recent Inorganic Growth Strategies in the Organoids Market

List Of Figures

  • Figure 1. Organoids Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Organoids Market Revenue (US$ Million), 2021-2031
  • Figure 5. Organoids Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Liver: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Stomach: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Pancreas: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Lung: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Brain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Kidney: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Organoids Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Organoids Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Organ Specific Adult Stem Cell: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Organoids Market Share (%) - by Offerings (2023 and 2031)
  • Figure 25. Instruments: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Consumables: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Services: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Organoids Market Share (%) - by Method (2023 and 2031)
  • Figure 29. Micropatterned Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Ultralow Attachment Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Hanging Drop: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Microdroplet/Emulsion: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 33. Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 34. Organoids Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 35. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. North America: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 37. North America: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 38. North America: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 39. North America: Organoids Market Breakdown, by Offerings (2023 and 2031)
  • Figure 40. North America: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 41. North America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 42. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. Europe: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 47. Europe: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 48. Europe: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 49. Europe: Organoids Market Breakdown, by Offerings (2023 and 2031)
  • Figure 50. Europe: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 51. Europe: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 52. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. France: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 55. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 56. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 57. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 58. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 59. Asia Pacific: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 60. Asia Pacific: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 61. Asia Pacific: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 62. Asia Pacific: Organoids Market Breakdown, by Offerings (2023 and 2031)
  • Figure 63. Asia Pacific: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 64. Asia Pacific: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 65. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 66. China: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 67. India: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 68. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 69. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 70. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 71. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 72. Middle East and Africa: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 73. Middle East and Africa: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 74. Middle East and Africa: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 75. Middle East and Africa: Organoids Market Breakdown, by Offerings (2023 and 2031)
  • Figure 76. Middle East and Africa: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 77. Middle East and Africa: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 78. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 79. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 80. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 81. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 82. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 83. South and Central America: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 84. South and Central America: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 85. South and Central America: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 86. South and Central America: Organoids Market Breakdown, by Offerings (2023 and 2031)
  • Figure 87. South and Central America: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 88. South and Central America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 89. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 90. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 91. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 92. Growth Strategies in Organoids Market